Cefepime Induced Encephalopathy Mimicking Acute Stroke
Journal of the Korean Neurological Association
;
: 372-375, 2019.
Article
Dans Coréen
| WPRIM
| ID: wpr-766822
ABSTRACT
Cefepime is a fourth-generation cephalosporin, developed in 1994, and is well known for its adverse effects. In 2002, the Food and Drug Administration adjusted the labeling to account for increased risk of seizures, encephalopathy and myoclonus, especially in the setting of renal impairment. Here we present a case of an 86-year-old female, undergoing Cefepime treatment, with encephalopathy mimicking acute stroke.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Crises épileptiques
/
Food and Drug Administration (USA)
/
Encéphalopathies
/
Accident vasculaire cérébral
/
Myoclonie
Limites du sujet:
Adulte très âgé
/
Aged80
/
Femelle
/
Humains
langue:
Coréen
Texte intégral:
Journal of the Korean Neurological Association
Année:
2019
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS